Nephros (NEPH) Equity Ratio (2010 - 2026)
Nephros' quarterly Equity Ratio came in at 0.78 in Q1 2026, down 1.66% year-on-year from 0.79 in Q1 2025, and up 3.73% quarter-over-quarter from 0.75 in Q4 2025.
Nephros has reported Equity Ratio for 17 years, with the latest figure at 0.78 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 1.66% year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (down 1.66% YoY), and the FY2025 full-year result was 0.75, down 2.34% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.78, up from 0.75 in the prior quarter.
- The five-year high for Equity Ratio was 0.86 in Q1 2022, with the low at 0.7 in Q4 2023.
- Average Equity Ratio over 5 years is 0.78, with a median of 0.79 recorded in 2024.
- Year-over-year, Equity Ratio declined 14.31% in 2024 and grew 10.09% in 2025.
- Tracing NEPH's Equity Ratio over 5 years: stood at 0.81 in 2022, then fell by 12.73% to 0.7 in 2023, then gained by 8.68% to 0.77 in 2024, then dropped by 2.34% to 0.75 in 2025, then grew by 3.73% to 0.78 in 2026.
- The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.75 (Q4 2025), and 0.76 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 0.88 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.47 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 0.74 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 0.73 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.35 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.67 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 0.66 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 0.30 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 0.52 |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Dec 31, 2025 | 0.75 |
| Sep 30, 2025 | 0.76 |
| Jun 30, 2025 | 0.78 |
| Mar 31, 2025 | 0.79 |
| Dec 31, 2024 | 0.77 |
| Sep 30, 2024 | 0.79 |
| Jun 30, 2024 | 0.71 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.70 |
| Sep 30, 2023 | 0.79 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.81 |
| Dec 31, 2022 | 0.81 |
| Sep 30, 2022 | 0.85 |
| Jun 30, 2022 | 0.83 |
| Mar 31, 2022 | 0.86 |
| Dec 31, 2021 | 0.84 |
| Sep 30, 2021 | 0.86 |
| Jun 30, 2021 | 0.83 |
| Mar 31, 2021 | 0.87 |
| Dec 31, 2020 | 0.84 |
| Sep 30, 2020 | 0.75 |
| Jun 30, 2020 | 0.74 |
| Mar 31, 2020 | 0.75 |
| Dec 31, 2019 | 0.66 |
| Sep 30, 2019 | 0.58 |
| Jun 30, 2019 | 0.57 |
| Mar 31, 2019 | 0.55 |
| Dec 31, 2018 | 0.64 |
| Sep 30, 2018 | 0.43 |
| Jun 30, 2018 | 0.66 |
| Mar 31, 2018 | 0.41 |
| Dec 31, 2017 | 0.39 |
| Sep 30, 2017 | 0.09 |
| Jun 30, 2017 | 0.28 |
| Mar 31, 2017 | 0.42 |
| Dec 31, 2016 | 0.25 |
| Sep 30, 2016 | 0.40 |
| Jun 30, 2016 | 0.42 |
| Mar 31, 2016 | 0.58 |
| Dec 31, 2015 | -0.67 |
| Sep 30, 2015 | 0.65 |
| Jun 30, 2015 | -1.75 |
| Mar 31, 2015 | -2.06 |
| Dec 31, 2014 | -1.69 |
| Sep 30, 2014 | -0.12 |
| Jun 30, 2014 | 0.09 |
| Mar 31, 2014 | 0.25 |
| Dec 31, 2013 | -1.29 |
| Sep 30, 2013 | 0.17 |
| Jun 30, 2013 | 0.29 |
| Mar 31, 2013 | -0.62 |
| Dec 31, 2012 | -0.17 |
| Sep 30, 2012 | 0.08 |
| Jun 30, 2012 | 0.21 |
| Mar 31, 2012 | 0.29 |
| Dec 31, 2011 | 0.36 |
| Sep 30, 2011 | 0.64 |
| Jun 30, 2011 | 0.80 |
| Dec 31, 2010 | 0.08 |